Serial Analysis of Gene Expression (SAGE) News and Research

RSS
2014 expected to be a banner year for brewed and RTD tea sales in the US

2014 expected to be a banner year for brewed and RTD tea sales in the US

Effective health interventions needed to increase life expectancy of older people

Effective health interventions needed to increase life expectancy of older people

Swimming-induced pulmonary oedema cases higher among athletes taking part in triathlons

Swimming-induced pulmonary oedema cases higher among athletes taking part in triathlons

Scandal-hit companies affect job prospects of even lower-ranking employees

Scandal-hit companies affect job prospects of even lower-ranking employees

TSRI, STSI researchers receive NIH grants to set up platforms to mine biomedical data

TSRI, STSI researchers receive NIH grants to set up platforms to mine biomedical data

Axio Research announces launch of Statistical Genetics and Genomics services

Axio Research announces launch of Statistical Genetics and Genomics services

Rosuvastatin drug more effective among prediabetic patients, finds new study

Rosuvastatin drug more effective among prediabetic patients, finds new study

UC Santa Cruz cancer researcher receives $350,000 to develop novel drugs for breast cancer

UC Santa Cruz cancer researcher receives $350,000 to develop novel drugs for breast cancer

Female veterans less likely to drink than civilian counterparts

Female veterans less likely to drink than civilian counterparts

Mothers who plan to breastfeed but return to work full-time are less likely to meet breastfeeding goals

Mothers who plan to breastfeed but return to work full-time are less likely to meet breastfeeding goals

Improving sleep patterns may help reduce level of cognitive decline in older adults

Improving sleep patterns may help reduce level of cognitive decline in older adults

SAGE reports preliminary data from SAGE-547 Phase 1/2 clinical trial for super-refractory status epilepticus

SAGE reports preliminary data from SAGE-547 Phase 1/2 clinical trial for super-refractory status epilepticus

Students from St. Louis win 2014 national Script Your Future Award

Students from St. Louis win 2014 national Script Your Future Award

The International Journal of Care Coordination to be re-launched in April 2014

The International Journal of Care Coordination to be re-launched in April 2014

Researchers develop screening tool to identify infants prior to 12 months at risk for ASD

Researchers develop screening tool to identify infants prior to 12 months at risk for ASD

Alcohol/sex frequency may cause resistance to HIV-prevention counseling

Alcohol/sex frequency may cause resistance to HIV-prevention counseling

New data sharing platform to advance cancer research: an interview with Dr. Charles Hugh-Jones, Chief Medical Officer, Sanofi U.S.

New data sharing platform to advance cancer research: an interview with Dr. Charles Hugh-Jones, Chief Medical Officer, Sanofi U.S.

PDS launches new data sharing platform to improve lives of cancer patients

PDS launches new data sharing platform to improve lives of cancer patients

Massachusetts Life Sciences Center provides $1.65M in capital grant to North Shore InnoVentures

Massachusetts Life Sciences Center provides $1.65M in capital grant to North Shore InnoVentures

SAGE Therapeutics doses first patient in SAGE-547 Phase 1/2 trial for treatment of SRSE

SAGE Therapeutics doses first patient in SAGE-547 Phase 1/2 trial for treatment of SRSE

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.